Abingworth Clinical Co-Development 3 Overview
Abingworth Clinical Co-Development 3 General Information
Description
Abingworth Clinical Co-Development 3 is an early-stage venture capital fund managed by Abingworth. The fund is located in London, United Kingdom.
Contact Information
Fund Manager's Location
- 1 Saint James's Market
- London SW1Y 4AH
- England, United Kingdom
Abingworth Clinical Co-Development 3 Investment Strategy
Investments by Industry
Investments by Deal Type
Abingworth Clinical Co-Development 3 Limited Partners (2)
Michigan Department of Treasury is one of Abingworth Clinical Co-Development 3’s 2 limited partners.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Michigan Department of Treasury | Current | Original | |||
| State of Michigan Retirement Systems | Public Pension Fund | Current | Original |
Abingworth Clinical Co-Development 3 Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Abingworth Clinical Co-Development 3 Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Abingworth Clinical Co-Development 3 Benchmark (10)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| AP Ventures Fund III | |||||
| Index Origin II | |||||
| Balderton Capital Growth II | 31-Mar-2026 | ||||
| Startupbootcamp Fund | |||||
| White Star Capital Fund IV | |||||
| Abingworth Clinical Co-Development 3 | |||||
| Hitachi Ventures Fund IV | |||||
| Index Ventures XII | 31-Dec-2025 | ||||
| Balderton Capital IX | 31-Mar-2026 | ||||
| Activate Capital Partners III |
Abingworth Clinical Co-Development 3 FAQs
-
What is Abingworth Clinical Co-Development 3?
Abingworth Clinical Co-Development 3 is an early-stage venture capital fund managed by Abingworth.
-
Who manages Abingworth Clinical Co-Development 3?
Abingworth Clinical Co-Development 3 is managed by Abingworth.
-
Where is Abingworth Clinical Co-Development 3 domiciled?
Abingworth Clinical Co-Development 3 is domiciled in United States: Delaware, Cayman Islands, and Luxembourg.
-
What is Abingworth Clinical Co-Development 3's size?
Abingworth Clinical Co-Development 3 has a size of $1.43B.
-
What type of fund is Abingworth Clinical Co-Development 3?
The fund type of Abingworth Clinical Co-Development 3 is Venture.
-
What is the status of Abingworth Clinical Co-Development 3?
Abingworth Clinical Co-Development 3 is closed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
